249 related articles for article (PubMed ID: 9825478)
1. Comparative analysis of diagnostic techniques for localization of gastrointestinal neuroendocrine tumors.
Gibril F; Jensen RT
Yale J Biol Med; 1997; 70(5-6):509-22. PubMed ID: 9825478
[TBL] [Abstract][Full Text] [Related]
2. Definition of the role of somatostatin receptor scintigraphy in gastrointestinal neuroendocrine tumor localization.
Jensen RT; Gibril F; Termanini B
Yale J Biol Med; 1997; 70(5-6):481-500. PubMed ID: 9825476
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor scintigraphy in gastrinomas.
Jensen RT; Gibril F
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S179-85. PubMed ID: 10604126
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.
Lebtahi R; Cadiot G; Sarda L; Daou D; Faraggi M; Petegnief Y; Mignon M; le Guludec D
J Nucl Med; 1997 Jun; 38(6):853-8. PubMed ID: 9189129
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study.
Gibril F; Reynolds JC; Doppman JL; Chen CC; Venzon DJ; Termanini B; Weber HC; Stewart CA; Jensen RT
Ann Intern Med; 1996 Jul; 125(1):26-34. PubMed ID: 8644985
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas.
Zimmer T; Stölzel U; Bäder M; Koppenhagen K; Hamm B; Buhr H; Riecken EO; Wiedenmann B
Gut; 1996 Oct; 39(4):562-8. PubMed ID: 8944566
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
[TBL] [Abstract][Full Text] [Related]
8. [Imaging of neuroendocrine tumors].
Gualdi GF; Casciani E; Polettini E
Clin Ter; 2001; 152(2):107-21. PubMed ID: 11441522
[TBL] [Abstract][Full Text] [Related]
9. Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS.
Kumbasar B; Kamel IR; Tekes A; Eng J; Fishman EK; Wahl RL
Abdom Imaging; 2004; 29(6):696-702. PubMed ID: 15162235
[TBL] [Abstract][Full Text] [Related]
10. The value of somatostatin-receptor scintigraphy in newly diagnosed endocrine gastroenteropancreatic tumors.
Kisker O; Bartsch D; Weinel RJ; Joseph K; Welcke UH; Zaraca F; Rothmund M
J Am Coll Surg; 1997 May; 184(5):487-92. PubMed ID: 9145069
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic ultrasonography of neuroendocrine tumours.
Zimmer T; Scherübl H; Faiss S; Stölzel U; Riecken EO; Wiedenmann B
Digestion; 2000; 62 Suppl 1():45-50. PubMed ID: 10940687
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy.
Proye C; Malvaux P; Pattou F; Filoche B; Godchaux JM; Maunoury V; Palazzo L; Huglo D; Lefebvre J; Paris JC
Surgery; 1998 Dec; 124(6):1134-43; discussion 1143-4. PubMed ID: 9854595
[TBL] [Abstract][Full Text] [Related]
13. [Somatostatin receptor scintigraphy and endoscopic ultrasound for the diagnosis of insulinoma and gastrinoma].
Zimmer T; Stölzel U; Liehr RM; Bäder M; Fett U; Hamm B; Wiedenmann B; Riecken EO
Dtsch Med Wochenschr; 1995 Jan; 120(4):87-93. PubMed ID: 7835241
[TBL] [Abstract][Full Text] [Related]
14. Localization of gastroenteropancreatic tumours by angiography.
Doppman JL; Jensen RT
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S163-6. PubMed ID: 10604123
[TBL] [Abstract][Full Text] [Related]
15. Single photon emission computed tomography procedure improves accuracy of somatostatin receptor scintigraphy in gastro-entero pancreatic tumours.
Schillaci O; Corleto VD; Annibale B; Scopinaro F; Delle Fave G
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S186-9. PubMed ID: 10604127
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.
Alexander HR; Fraker DL; Norton JA; Bartlett DL; Tio L; Benjamin SB; Doppman JL; Goebel SU; Serrano J; Gibril F; Jensen RT
Ann Surg; 1998 Aug; 228(2):228-38. PubMed ID: 9712569
[TBL] [Abstract][Full Text] [Related]
17. [Imaging methods in diagnosis of neuroendocrine tumors of the gastrointestinal tract].
Zimmer T; Faiss S; Buhr HJ; Hamm B; Wiedenmann B
Bildgebung; 1995 Mar; 62(1):5-13. PubMed ID: 7756824
[TBL] [Abstract][Full Text] [Related]
18. [Significance of false-positive findings of somatostatin receptor scintigraphy in diagnosis of neuroendocrine tumors of the gastroenteropancreatic system].
Faiss S; Scherübl H; Bäder M; Fett U; Koppenhagen K; Wiedenmann B; Riecken EO
Z Gastroenterol; 1994 May; 32(5):243-6. PubMed ID: 7915450
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of somatostatin receptor scintigraphy.
Kwekkeboom DJ; Lamberts SW; Habbema JD; Krenning EP
J Nucl Med; 1996 Jun; 37(6):886-92. PubMed ID: 8683305
[TBL] [Abstract][Full Text] [Related]
20. Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.
Namwongprom S; Wong FC; Tateishi U; Kim EE; Boonyaprapa S
Ann Nucl Med; 2008 May; 22(4):237-43. PubMed ID: 18535873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
